Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28319093 | 0.98 | ALDH1A1 (0.54) | ALDH1A1ADRA2BPTGS1TDP1CA12 | |
| SCHEMBL27467769 | 0.87 | ALDH1A1 (0.48) | ALDH1A1ADRA2BPTGS1TDP1KDM4E | |
| SCHEMBL28281191 | 0.85 | ALDH1A1 (0.58) | ALDH1A1ADRA2BPTGS1TDP1CA12 | |
| SCHEMBL1547302 | 0.84 | CA1 (0.52) | ALDH1A1ADRA2BPTGS1TDP1CA12 | |
| SCHEMBL11289542 | 0.84 | ALDH1A1 (0.52) | ALDH1A1ADRA2BPTGS1TDP1CA12 | |
| SCHEMBL1161645 | 0.83 | ALDH1A1 (0.56) | ALDH1A1ADRA2BPTGS1TDP1CA12 | |
| SCHEMBL1374548 | 0.83 | ALDH1A1 (0.56) | ALDH1A1ADRA2BPTGS1TDP1CA12 | |
| SCHEMBL4763029 | 0.83 | ALDH1A1 (0.56) | ALDH1A1ADRA2BPTGS1TDP1CA12 | |
| SCHEMBL30873744 | 0.83 | ALDH1A1 (0.56) | ALDH1A1ADRA2BPTGS1TDP1CA12 | |
| SCHEMBL18185043 | 0.82 | ALDH1A1 (0.54) | ALDH1A1ADRA2BPTGS1TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9249091-B2 | Post-treated sulfurized salt of an alkyl-substituted hydroxyaromatic composition | CHEVRON ORONITE COMPANY LLC (US) | 2016-02-02 | — | — | US | claimed |
| US-20130165359-A1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | CHEVRON ORONITE COMPANY LLC (US) | 2013-06-27 | — | — | US | claimed |
| US-8288552-B2 | Dihydropyridone amidesas P2X7 modulators | ROCHE PALO ALTO LLC (US) | 2012-10-16 | — | — | US | claimed |
| US-7056986-B2 | ethylene monomer can be a vinyl ketone, ether, ester, halide, nitrile, aromatic, or an allyl ether; acrylic monomer can be a mono- or diacid or monoester of a diacid; a monoamine, a guanidine compound, and an aromatic diamine; improved vulcanizability, balance between processability and compression set | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2006-06-06 | — | — | US | claimed |
| CN-110249004-B | Polyimide precursor composition | 东京应化工业株式会社 | 2022-07-19 | — | — | CN | disclosed |
| CN-108774561-B | Sulfurized salts of post-treated alkyl-substituted hydroxyaromatic compositions | 雪佛龙奥伦耐有限责任公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-108389512-B | Laminate, flexible device, and method for producing laminate | 东京应化工业株式会社 | 2022-04-15 | — | — | CN | disclosed |
| CN-108387954-B | Laminate, flexible device, and method for producing laminate | 东京应化工业株式会社 | 2022-01-18 | — | — | CN | disclosed |
| US-10954340-B2 | Polyimide precursor composition | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-03-23 | — | — | US | disclosed |
| CN-107922733-B | Polyimide precursor composition | 东京应化工业株式会社 | 2020-09-11 | — | — | CN | disclosed |
| EP-2798050-B1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | CHEVRON ORONITE CO (US) | 2020-04-22 | — | — | EP | disclosed |
| WO-2020065613-A1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-04-02 | — | — | WO | disclosed |
| CN-1286815-C | 4-anilinoquinoline-3-carboxamides | ASTRAZENECA AB (SE) | 2006-11-29 | — | — | CN | disclosed |
| EP-1685124-A1 | SUBSTITUTED NITROGEN-CONTAINING SIX-MEMBERED AMINO-HETEROCYCLES AS VANILLOID-1 RECEPTOR ANTAGONISTS FOR TREATING PAIN | MERCK SHARP & DOHME LTD. (GB) | 2006-08-02 | — | — | EP | disclosed |
| US-7056986-B2 | ethylene monomer can be a vinyl ketone, ether, ester, halide, nitrile, aromatic, or an allyl ether; acrylic monomer can be a mono- or diacid or monoester of a diacid; a monoamine, a guanidine compound, and an aromatic diamine; improved vulcanizability, balance between processability and compression set | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2006-06-06 | — | — | US | disclosed |
| US-20050197342-A1 | Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain | HOLLINGWORTH GREGORY J (GB) | 2005-09-08 | — | — | US | disclosed |
| WO-2005047279-A1 | SUBSTITUTED NITROGEN-CONTAINING SIX-MEMBERED AMINO-HETEROCYCLES AS VANILLOID-1 RECEPTOR ANTAGONISTS FOR TREATING PAIN | MERCK SHARP & DOHME LIMITED (GB) | 2005-05-26 | — | — | WO | disclosed |
| US-20040266922-A1 | Ethylene-acrylic copolymer rubber composition | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2004-12-30 | — | — | US | disclosed |
| EP-1449881-A1 | ACRYLIC RUBBER COMPOSITION | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2004-08-25 | — | — | EP | disclosed |
| CN-1507434-A | Novel 4-anilinoquinoline-3-carboxamides | — | 2004-06-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197342-A1 | Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain | OPRL1, OPRK1, CNR1 | ALDH1A1 2879/4885ADRA2B 268/4885PTGS1 331/4885 |
| US-20130165359-A1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | TST, PAH, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ALDH1A1 814/4885ADRA2B 541/4885PTGS1 2035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.